HUP0002949A2 - Immunitást fokozó tejsavbaktériumok - Google Patents

Immunitást fokozó tejsavbaktériumok

Info

Publication number
HUP0002949A2
HUP0002949A2 HU0002949A HUP0002949A HUP0002949A2 HU P0002949 A2 HUP0002949 A2 HU P0002949A2 HU 0002949 A HU0002949 A HU 0002949A HU P0002949 A HUP0002949 A HU P0002949A HU P0002949 A2 HUP0002949 A2 HU P0002949A2
Authority
HU
Hungary
Prior art keywords
lactic acid
acid bacteria
immunity enhancing
enhancing lactic
dated
Prior art date
Application number
HU0002949A
Other languages
English (en)
Inventor
Harshamjit S. Gill
Pramod K. Gopal
John B. Smart
Original Assignee
New Zealand Dairy Board
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO8699A external-priority patent/AUPO869997A0/en
Priority claimed from AUPP3225A external-priority patent/AUPP322598A0/en
Application filed by New Zealand Dairy Board filed Critical New Zealand Dairy Board
Publication of HUP0002949A2 publication Critical patent/HUP0002949A2/hu
Publication of HUP0002949A3 publication Critical patent/HUP0002949A3/hu
Publication of HU228046B1 publication Critical patent/HU228046B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/23—Lactobacillus acidophilus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/854—Lactobacillus acidophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Seasonings (AREA)

Abstract

A találmány új, Lactobacillus rhamnosus HN001 és HN067, Lactobacillusacidophilus HN017, valamint Bifidobacterium lactis HN019baktériumtörzsekre vonatkozik. Az emésztőrendszerbe kerülve a szóbanforgó törzsek fokozzák az immunválaszt. Ó
HU0002949A 1997-08-21 1998-08-18 Immunity enhancing lactic acid bacteria HU228046B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO8699A AUPO869997A0 (en) 1997-08-21 1997-08-21 Immuno-enhancing composition
AUPP3225A AUPP322598A0 (en) 1998-04-28 1998-04-28 Immunity-enhancing lactic acid bacteria
PCT/NZ1998/000122 WO1999010476A1 (en) 1997-08-21 1998-08-18 Immunity enhancing lactic acid bacteria

Publications (3)

Publication Number Publication Date
HUP0002949A2 true HUP0002949A2 (hu) 2000-12-28
HUP0002949A3 HUP0002949A3 (en) 2003-03-28
HU228046B1 HU228046B1 (en) 2013-03-28

Family

ID=25645584

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002949A HU228046B1 (en) 1997-08-21 1998-08-18 Immunity enhancing lactic acid bacteria

Country Status (22)

Country Link
US (1) US6379663B1 (hu)
EP (2) EP1007625B1 (hu)
JP (1) JP3694236B2 (hu)
KR (1) KR100406344B1 (hu)
CN (1) CN1150314C (hu)
AU (1) AU727940B2 (hu)
BR (1) BR9811332A (hu)
DE (1) DE69841826D1 (hu)
DK (2) DK1007625T3 (hu)
ES (2) ES2349669T3 (hu)
GB (1) GB2338245B (hu)
HK (1) HK1024719A1 (hu)
HU (1) HU228046B1 (hu)
ID (1) ID24734A (hu)
MY (1) MY116272A (hu)
NZ (1) NZ337520A (hu)
PL (1) PL195110B1 (hu)
RU (1) RU2208632C2 (hu)
SK (1) SK283008B6 (hu)
TR (1) TR200000451T2 (hu)
TW (1) TW587098B (hu)
WO (1) WO1999010476A1 (hu)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2349669T3 (es) * 1997-08-21 2011-01-10 New Zealand Dairy Board Bacterias del ácido láctico que incrementan la inmunidad.
EP1034788A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactic acid bacteria strains capable of preventing diarrhea
ES2155783B1 (es) * 1999-05-07 2002-05-16 Danone Sa Nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos.
ES2155782B1 (es) * 1999-05-07 2002-05-16 Danone Sa Utilizacion de bacterias acidolacticas pra preparar leches fermentadas para el tratamiento de niveles de actividad inmunitaria transitoriamente reducidos.
WO2000067583A2 (en) * 1999-05-07 2000-11-16 Compagnie Gervais Danone Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
US7125698B2 (en) * 1999-08-09 2006-10-24 Matthew Glenn Polynucleotides, materials incorporating them, and methods for using them
HU227086B1 (en) * 1999-11-25 2010-06-28 Vakcina Kft Lactobacillus vaccine for treating prostata inflammatory and benign prostata hyperplasia
FR2809312B1 (fr) * 2000-05-25 2002-07-12 Gervais Danone Sa Utilisation de l. casei dans des compositions immunostimulantes
TW588109B (en) * 2000-07-29 2004-05-21 Tcell Biotechnology Food Co Lt Lactobacillus rhamnosus strain and uses thereof
AU8455801A (en) * 2000-08-08 2002-02-18 Genesis Res & Dev Corp Ltd Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
SG97174A1 (en) * 2000-12-19 2003-07-18 Cell Biotechnology Food Co Ltd Lactobacillus rhamnosus strain and uses thereof
FI109602B (fi) 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
US20030017192A1 (en) * 2001-06-19 2003-01-23 Hanny Kanafani Process for producing extended shelf-life ready-to-use milk compositions containing probiotics
KR100442205B1 (ko) * 2002-02-28 2004-07-30 주식회사 비피도 β- 글루코시다제를 생산하는 비피도박테리움 락티스 및이를 이용하여 이소플라본을 이소플라본 비배당체로전환하는 방법
US20040047849A1 (en) * 2002-09-11 2004-03-11 Genmont Biotech Inc. Use of some lactobacillus strains in treating allergy
NZ521836A (en) * 2002-10-08 2005-07-29 New Zealand Dairy Board High pressure treatment to reduce microbial spoilage in cultured dairy foods, cooked meats, vegetables and the like
US7740838B2 (en) * 2002-12-05 2010-06-22 Danisco A/S Bacterial composition and its use
US7001756B1 (en) * 2004-02-19 2006-02-21 Genmont Biotech Inc. Microorganism strain of GM-020 of Lactobacillus rhamnosus and its use for treating obesity
US6994848B2 (en) * 2004-03-25 2006-02-07 Genmont Biotech Inc. Lactobacillus paracasei strain GM-080 for treating allergy related diseases
ITMI20042189A1 (it) 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
RU2270248C1 (ru) * 2004-12-31 2006-02-20 Открытое акционерное общество "Лианозовский молочный комбинат" Штамм бифидобактерий bifidobacterium lactis 668, используемый для приготовления кисломолочных, ферментированных и неферментированных пищевых продуктов, биологически активных добавок, бактериальных препаратов и косметических средств
BRPI0609093B1 (pt) 2005-05-11 2018-12-18 Chr Hansen As processo para preparar uma cepa de bifidobacterium sp. que contém um gene tetw mutante em seu cromossomo, cepa de bifidobacterium e uso da mesma
ES2323712T3 (es) * 2005-05-11 2009-07-23 Chr. Hansen A/S Cepas de bacterias de acido lactico sensibles a los antibioticos.
JP2007028920A (ja) * 2005-07-22 2007-02-08 Japan Research & Development Association For New Functional Foods 発酵乳およびその製造方法
KR20080059581A (ko) 2005-10-13 2008-06-30 메이지 세이카 가부시키가이샤 장내 플로라 개선용 조성물
WO2008058854A1 (en) * 2006-11-15 2008-05-22 Chr. Hansen A/S New tetracycline-sensitive bifidobacteria strains
TWI356680B (en) 2007-01-05 2012-01-21 Promd Biotech Co Ltd Anti-allergy lactic acid bacteria
FR2928935B1 (fr) * 2008-03-19 2011-05-20 Gervais Danone Sa Souche de lactobacillus rhamnosus.
EP2344148B2 (en) * 2008-09-19 2024-05-08 Société des Produits Nestlé S.A. Nutritional support to prevent or moderate bone marrow paralysis during anti-cancer treatment
CA2744778C (en) * 2008-11-28 2019-01-15 University Of Otago Use of lactic acid bacteria to treat or prevent eczema
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
NZ601141A (en) * 2010-01-19 2014-07-25 Abbott Lab Nutritional formulas containing synbiotics
WO2011141762A1 (en) 2010-05-12 2011-11-17 Compagnie Gervais Danone Synergistic fermentation of lactobacillus rhamnosus and lactobacillus paracasei subsp paracasei
WO2012063345A1 (ja) * 2010-11-11 2012-05-18 株式会社カザミ 免疫賦活剤及びそれを配合した免疫賦活組成物、並びに免疫賦活方法
RU2453591C1 (ru) * 2011-04-21 2012-06-20 Общество с ограниченной ответственностью "Бифилюкс" Штамм lactobacillus rhamnosus, используемый для получения продукции, содержащей лактобактерии
WO2013101516A1 (en) 2011-12-29 2013-07-04 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using extracted genomic dna
ITRM20130174A1 (it) * 2013-03-22 2014-09-23 Eurospital S P A Ceppo di lactobacillus e suo uso come probiotico
NZ750365A (en) 2016-07-28 2022-07-01 Fonterra Cooperative Group Ltd Dairy product and process
EP4136985A1 (en) 2016-12-22 2023-02-22 University of Otago Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
JP7092380B2 (ja) 2016-12-22 2022-06-28 ユニバーシティ オブ オタゴ 妊娠糖尿病を治療又は予防するための乳酸菌の使用
KR102591869B1 (ko) 2017-06-02 2023-10-19 유니버시티 오브 오타고 산후 우울증 및 산후 불안 중 적어도 하나를 처치하거나 예방하기 위한 락트산 박테리아의 용도
KR20230085712A (ko) 2021-12-07 2023-06-14 주식회사 에이스브이 버터플라이 밸브용 디스크 락킹 장치

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0614862B2 (ja) 1987-05-22 1994-03-02 東京田辺製薬株式会社 ビフィドバクテリウム菌の増殖促進剤
JP2617758B2 (ja) * 1988-03-25 1997-06-04 株式会社ヤクルト本社 抗体産生増強型免疫賦活剤
JPH0551321A (ja) * 1991-08-23 1993-03-02 Yotsuba Nyugyo Kk 免疫賦活剤
DK0768375T4 (da) 1992-07-06 2002-09-16 Nestle Sa Mælkesyrebakterier
EP0686039B1 (en) 1993-02-24 2000-08-23 Valio Ltd. Method of enhancing immune response to oral vaccines
WO1994026114A1 (en) * 1993-05-11 1994-11-24 Immunom Technologies, Inc. Method of stimulating and modulating the immune system of animals with microbial compositions
JP4112021B2 (ja) * 1994-02-16 2008-07-02 明治乳業株式会社 乳酸菌を用いた免疫賦活剤
JPH092959A (ja) * 1995-06-16 1997-01-07 Yakult Honsha Co Ltd ＩｇＥ抗体産生抑制剤および抗アレルギー剤
FI102298B1 (fi) * 1995-09-07 1998-11-13 Oulutech Oy Menetelmä maitohappobakteerilajien määrittämiseksi ja menetelmään soveltuvia oligonukleotideja
ES2283027T3 (es) * 1996-11-29 2007-10-16 Bio K + International Inc. Fermento lactico que comprende una cepa particular de lactobacilus acidofilus y utilizacion del mismo.
ES2349669T3 (es) * 1997-08-21 2011-01-10 New Zealand Dairy Board Bacterias del ácido láctico que incrementan la inmunidad.

Also Published As

Publication number Publication date
GB2338245B (en) 2001-11-21
US6379663B1 (en) 2002-04-30
EP1007625A4 (en) 2004-12-01
SK2192000A3 (en) 2000-09-12
EP1007625B1 (en) 2010-08-11
CN1150314C (zh) 2004-05-19
NZ337520A (en) 2000-01-28
CN1264422A (zh) 2000-08-23
HUP0002949A3 (en) 2003-03-28
HU228046B1 (en) 2013-03-28
JP2001513990A (ja) 2001-09-11
EP1007625A1 (en) 2000-06-14
KR100406344B1 (ko) 2003-11-19
WO1999010476A1 (en) 1999-03-04
ES2349669T3 (es) 2011-01-10
TW587098B (en) 2004-05-11
RU2208632C2 (ru) 2003-07-20
AU727940B2 (en) 2001-01-04
TR200000451T2 (tr) 2000-06-21
GB9920043D0 (en) 1999-10-27
DK2241616T3 (da) 2013-02-18
MY116272A (en) 2003-12-31
SK283008B6 (sk) 2003-01-09
ES2399324T3 (es) 2013-03-27
ID24734A (id) 2000-08-03
HK1024719A1 (en) 2000-10-20
AU9009598A (en) 1999-03-16
EP2241616B1 (en) 2012-11-28
KR20010023117A (ko) 2001-03-26
GB2338245A (en) 1999-12-15
EP2241616A1 (en) 2010-10-20
PL338775A1 (en) 2000-11-20
US20020031503A1 (en) 2002-03-14
BR9811332A (pt) 2000-09-19
PL195110B1 (pl) 2007-08-31
DE69841826D1 (de) 2010-09-23
DK1007625T3 (da) 2010-11-01
JP3694236B2 (ja) 2005-09-14

Similar Documents

Publication Publication Date Title
HUP0002949A2 (hu) Immunitást fokozó tejsavbaktériumok
HUP0003744A3 (en) Lactobacillus helveticus bacterium having high capability of producing tripeptide, fermented milk product, and process for preparing the same
EP1188822A4 (en) L-AMINO ACID-PRODUCING BACTERIUM AND METHOD FOR PRODUCING L-AMINO ACID
GR3025971T3 (en) Agent antigastrite contenant lactobacillus acidophilus
CA2099856A1 (en) Lactic Acid Bacterium
RU93049638A (ru) Молочно-кислая бактерия
NO991135D0 (no) Dehydrert nµringsmiddel inneholdende melkesyrebakterier
DE69517721T2 (de) Milchsäurebakterien der Gattung Lactobacillus
GR3018081T3 (en) Yogurt containing living microorganisms.
AU3847597A (en) Metabolically engineered lactic acid bacteria and their use
IL134410A0 (en) Novel lactic acid bacteria
EP0652285A3 (en) Lactic acid bacteria and fermented milk product.
ZA938823B (en) Bioreactor with immobilized lactic acid bacteria and the use thereof.
GR3032933T3 (en) Inhibition of clostridia with lactic acid bacteria
ZA969111B (en) Lactic ferments and their use for the production of hypocholesterolaemic products.
AU1276300A (en) Selection and uses of lactic acid bacteria strains modulating non-specific immunity
WO2000067583A3 (en) Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
IT9047536A1 (it) Ceppo di batteri lactobacillus casei subsp. casei 37 per la produzione di un preparato biologico batteriale.
AU3765997A (en) Metabolically engineered lactic acid bacteria and means for providing same
RU97116294A (ru) Консорциум микроорганизмов lactobacillus dcidoplulus. lactobacillus dilbruicu sub.bulgaricus, sacharomyces
ZA908475B (en) Supported lactic acid bacteria cultures
AU6427300A (en) Phage resistant lactic acid bacterial mutants
AU3821095A (en) Vaccine preparation recovered from bacteria grown in iron-rich media
PL349543A1 (en) Novel strain of lactic bacteria lactobacillus bulgaricus
RU92015321A (ru) Консорциум бактерий (streptococcus thermophilus, streptococcus fovis, lactobacillus salivarius var, salicinicus, lactobacillus salivarius var.salivarius, lactobacillus acidobhilus) 5842 для активации почвенной микрофлоры